Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
04/2001
04/12/2001CA2384696A1 Fibroblast growth factor-5 (fgf-5) is a tumor associated t-cell antigen
04/12/2001CA2382859A1 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization
04/12/2001CA2382830A1 Chromogenic substrates of sialidase of bacterial, viral, protozoa, and vertebrate origin and methods of making and using the same
04/12/2001CA2380807A1 Alterations in the long qt syndrome genes kvlqt1 and scn5a and methods for detecting same
04/12/2001CA2379462A1 Human g-protein coupled receptor
04/11/2001EP1091211A1 Metal chelate containing compositions for use in chemiluminescent assays
04/11/2001EP1091004A2 Simultaneous detection, identification and differentiation of Eubacterial taxa using a hybridization assay
04/11/2001EP1091003A2 Improvements in or relating to detection of microorganisms in plant material
04/11/2001EP1091002A2 Sequential activation of one or more enzymatic activities within a thermocycling reaction for synthesizing DNA molecules
04/11/2001EP1090997A1 Hcv-derived rna polymerase gene
04/11/2001EP1090995A2 Mycoplasma hyopneumoniae antigen MHP3, gene encoding it and uses thereof
04/11/2001EP1090991A1 Novel nicotinic acetylcholine receptor subunit, its isolation and use
04/11/2001EP1090990A1 Human g-protein-coupled receptor
04/11/2001EP1090989A1 Human g-protein-coupled receptor
04/11/2001EP1090988A1 Methods for the production of recombinant citrate lyase holo-enzyme
04/11/2001EP1090987A1 Cell cycle regulatory factor
04/11/2001EP1090986A1 Protein rim 2
04/11/2001EP1090985A1 Feline-derived T-cells
04/11/2001EP1090926A1 Human G-protein coupled receptor
04/11/2001EP1090925A1 Human G-protein coupled receptor
04/11/2001EP1090299A1 Methods of detecting t-cell activation
04/11/2001EP1090295A1 Methods for rapidly identifying small organic ligands
04/11/2001EP1090294A1 Methods for determining presence of cancer in a sample by determining expression of an ssx gene, peptides derived from said ssx gene and ny-eso-1 gene, and uses thereof
04/11/2001EP1090293A2 Decoding of array sensors with microspheres
04/11/2001EP1090291A1 Method for early diagnosis of, and determination of prognosis in, cancer
04/11/2001EP1090286A1 Multi-sensor array for electrochemical recognition of nucleotide sequences and methods
04/11/2001EP1090279A2 Screening method for dehydrogenase oligomerisation modulators
04/11/2001EP1090147A2 Method for detection of drug-selected mutations in the hiv protease gene
04/11/2001EP1090146A1 Uses of dna-pk
04/11/2001EP1090145A2 Binding acceleration techniques for the detection of analytes
04/11/2001EP1090144A1 Method for detecting, analyzing, and mapping rna transcripts
04/11/2001EP1090143A1 Method for quantifying tgf-beta
04/11/2001EP1090142A1 Methods for determining breast cancer and melanoma by assaying for a plurality of antigens associated therewith
04/11/2001EP1090141A1 Rapid heat block thermocycler
04/11/2001EP1090140A1 Method for screening for substances which are activators or inhibitors of protein kinase b
04/11/2001EP1090139A1 Ph-indicator based assay for selective enzymes
04/11/2001EP1090138A1 Nucleotide detection method
04/11/2001EP1090135A2 Methods to screen herbicidal compounds utilizing air synthetase from arabidopsis thaliana
04/11/2001EP1090122A1 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses
04/11/2001EP1090118A2 Human signal peptide-containing proteins
04/11/2001EP1090116A2 Transgenic non-human animal which comprises an inactive peg3 gene, and the use thereof
04/11/2001EP1090112A1 Human arf-related proteins
04/11/2001EP1090111A1 Exhaustive analysis of viral protein interactions by two-hybrid screens and selection of correctly folded viral interacting polypeptides
04/11/2001EP1090110A2 Human vault rna
04/11/2001EP1090106A2 Alkylamines and their precursors as specific modulators of human gamma-delta t cell function
04/11/2001EP1090104A1 Methods of expanding and selecting disease associated t-cells
04/11/2001EP1090073A1 Xanthene dyes and their application as luminescence quenching compounds
04/11/2001EP1090033A1 Particles of hcv envelope proteins: use for vaccination
04/11/2001EP1089794A2 Methods for inhibiting tef-3 activity
04/11/2001EP1089765A2 $i(IN VIVO) DETERMINATION OF METABOLIC FUNCTION FOR USE IN THERAPY MANAGEMENT
04/11/2001EP0912597A4 Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
04/11/2001EP0876492A4 Novel methods for the characterization of compounds which stimulate stf-1 expression in pancreatic islet cells
04/11/2001CN1291240A Method for characterisation of nucleic acid molecules involving generation of extendable upstream DNA fragments resulting from the cleavage of nucleic acid of an abasic site
04/11/2001CN1291234A Isolated and purified mucleic acids comprising a gene specifically expressed in hop glands
04/11/2001CN1291231A Human telomerase catalytic subunit
04/11/2001CN1291228A Enzyme catalyzed therapeutic agents
04/11/2001CN1291096A Use of inhibitors for treatment of disorders related to RTK hyperfunction
04/11/2001CN1290859A Method and device for on-line monitoring waste water
04/11/2001CN1290752A Compound micro path array chip and its preparing method
04/11/2001CN1290749A Charcot-leyden crystal IB and its coding sequence and producing method and use
04/11/2001CN1290748A New human protein and its coding sequence, and producing method and use
04/11/2001CN1290747A New human metal thioalbumen and its coding sequence
04/10/2001US6216049 Computerized method and apparatus for analyzing nucleic acid assay readings
04/10/2001US6214983 Isolated nucleic acid molecules which encode SCP proteins
04/10/2001US6214982 Ribonuclease resistant RNA preparation and utilization
04/10/2001US6214980 Polynucleotide which codes for formyl-coenzyme a transferase; probes; primers
04/10/2001US6214979 Homogeneous assay system
04/10/2001US6214972 Human receptor of defined amino acid sequence; for recombinant preparation of membranes for screening agonists and antagonists; treatment of sleep disorders, allergic rhinitis, glaucoma, congestive heart failure; antiinflammatory agents
04/10/2001US6214970 Hepatitis E virus antigens and uses therefor
04/10/2001US6214865 Anticancer agent
04/10/2001US6214625 Composition and method for differentiation of basophils and eosinophils in blood
04/10/2001US6214616 Homozygous p53 gene-defective human colonic cell line
04/10/2001US6214612 Cholesterol sensor containing electrodes, cholesterol dehydrogenase, nicotinamide adenine dinucleotide and oxidized electron mediator
04/10/2001US6214600 Polypeptide of defined amino acid sequence; treatment of alzheimer's disease, stroke, musculoskeletal disease, heart disease, kidney disease; anticarcinogenic/antiinflammatory agents; antiarthritic agents; diagnosis
04/10/2001US6214595 Enzymatic polypeptide for utilization in screening bactericides; wound healing agents; for prevent of bacterial wound infections
04/10/2001US6214587 Accumulating target nucleotide sequences; mixing primers, nucleotide sequences and preferential polymerase, heat, allow hybridization of primers and accumulation of nucleotide sequences, recover preferential sequences
04/10/2001US6214583 HCV genomic sequences for diagnostics and therapeutics
04/10/2001US6214571 Method for inhibiting adenylosuccinate synthetase activity in malignant methylthioadenosine phosphorylase deficient cells
04/10/2001US6214570 Separating high density lipoproteins from body fluids; incubate body fluid with porous carrier, precipitate polypeptides, incubate remaining body fluid with second porous carrier, separate the different lipoproteins
04/10/2001US6214569 Detecting therapeutic agents for treatment of nervous system disorders; incubate modulators and test compound, monitor reduction in the formation of peptide filaments in cells
04/10/2001US6214567 Testing antitumor agents; obtain preferential human tissue and incubate with antitumor agent, evaluate propagtion of tumorous cells
04/10/2001US6214565 Assay for disease related conformation of a protein and isolating same
04/10/2001US6214564 Method of identifying modulators of protein tyrosine phosphatase activity
04/10/2001US6214563 Such as in fluorescence assays in living cells; photon reducing agent is a dye such as tarazine
04/10/2001US6214560 Analyte assay using particulate labels
04/10/2001US6214558 Diagnosing fetal genome mutation; insert nucleotide sequence probe in to sample, allow hybridization, wash sample, determine if adjustments exists in genome and whether they are indicative chromosomal mutation
04/10/2001US6214557 Cold sensitive mutant DNA polymerases
04/10/2001US6214556 Classification and differentiation of tissues and cells; rearrange cytosine to uracil in nucleotide sequences, amplify rearranged nucleotide sequences, detect hybridization products and determine phenotype of cells
04/10/2001US6214555 Method compositions and kit for detection
04/10/2001US6214554 Chronic fatigue syndrome diagnosis
04/10/2001US6214553 Libraries of protein encoding RNA-protein fusions
04/10/2001US6214552 Assays for measuring nucleic acid damaging activities
04/10/2001US6214549 Contacting sample with probe comprising stem and branch such that substance if present binds directly or indirectly to probe; mixing binding product with conjugate; removing unbound conjugate from mixture; determining presence of conjugate
04/10/2001US6214548 Diagnostic methods for Cyclospora
04/10/2001US6214546 Detection of biomolecules
04/10/2001US6214545 Polymorphism analysis by nucleic acid structure probing
04/10/2001US6214544 Method to identify tumor suppressor genes
04/10/2001US6214543 DNA molecule encoding for cellular uptake of Mycobacterium tuberculosis and uses thereof
04/10/2001US6214542 Diagnosis of fibrotic defects; obtain tissue sample, obtain segment of sample, isolate messenger ribonucleic acid sequences, reverse transcribe and isolate amplify nucleic acid, correlate nucleic acid amounts with defect
04/10/2001US6214540 Chemokines that inhibit immunodeficiency virus infection and methods based thereon